| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2135071 | Experimental Hematology | 2009 | 17 Pages |
Abstract
MEDII treatment of hESCs and hiPSCs alike selectively enhances their differentiation into mesodermal cells and allows subsequent generation of detectable levels of hematopoietic progenitors with in vitro and in vivo differentiating activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Min Lu, Melanie D. Kardel, Michael D. O'Connor, Connie J. Eaves,